Repetitive Busulfan Administration After Hematopoietic Stem Cell Gene Therapy Associated with a Dominant HDAC7 Clone in a Nonhuman PrimateJIANJUN XIE; LAROCHELLE, Andre; MARIC, Irina et al.Human gene therapy. 2010, Vol 21, Num 6, pp 695-703, issn 1043-0342, 9 p.Article

DNA intrastrand cross-link at the 5'-GA-3' sequence formed by busulfan and its role in the cytotoxic effectIWAMOTO, Takuya; HIRAKU, Yusuke; OIKAWA, Shinji et al.Cancer science. 2004, Vol 95, Num 5, pp 454-458, issn 1347-9032, 5 p.Article

Unreported use of an herbal supplement resulting in decreased clearance of intravenous busulfan in a patient undergoing auto-SCTCARTER, J; YEH, R. F; BRAUNSCHWEIG, I et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 2, pp 313-314, issn 0268-3369, 2 p.Article

Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemiaFARAG, S. S; WOOD, L. L; SULLIVAN, C et al.Leukemia. 2011, Vol 25, Num 4, pp 599-605, issn 0887-6924, 7 p.Article

The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodelingVALDEZ, Benigno C; YANG LI; MURRAY, David et al.Biochemical pharmacology. 2011, Vol 81, Num 2, pp 222-232, issn 0006-2952, 11 p.Article

Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureusZIMECKI, Michat; ARTYM, Jolanta; KOCIEBA, Maja et al.Medical microbiology and immunology. 2010, Vol 199, Num 2, pp 71-79, issn 0300-8584, 9 p.Article

Quantitative Analysis of Busulfan in Human Plasma by LC-MS-MSLINGYUN CHEN; ZHIFENG ZHOU; MEI SHEN et al.Chromatographia (Wiesbaden). 2009, Vol 70, Num 11-12, pp 1727-1732, issn 0009-5893, 6 p.Article

Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patientsMUNKELT, Doreen; KOEHL, Ulrike; KLINGEBIEL, Thomas et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 821-830, issn 0344-5704, 10 p.Article

Optimal Prevention of Seizures Induced by High-Dose BusulfanEBERLY, Andrea L; ANDERSON, Gail D; BUBALO, Joseph S et al.Pharmacotherapy. 2008, Vol 28, Num 12, pp 1502-1510, issn 0277-0008, 9 p.Article

Advances in the treatment of chronic granulomatous disease by gene therapyOTT, Marion G; SEGER, Reinhard; STEIN, Stefan et al.Current gene therapy. 2007, Vol 7, Num 3, pp 155-161, issn 1566-5232, 7 p.Article

Elevated plasma ferritin and busulfan pharmacodynamics during high-dose chemotherapy regimens in children with malignant solid tumorsBOULIGAND, J; LE MAITRE, A; VALTEAU-COUANET, D et al.Clinical pharmacology and therapeutics. 2007, Vol 82, Num 4, pp 402-409, issn 0009-9236, 8 p.Article

Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 gy total body irradiationONISHI, Yasushi; MORI, Shin-Ichiro; TOBINAI, Kensei et al.International journal of hematology. 2007, Vol 85, Num 3, pp 256-263, issn 0925-5710, 8 p.Article

Early morphological changes leading to central polydactyly, syndactyly, and central deficiencies : An experimental study in ratsNARUSE, Takuji; TAKAHARA, Masatoshi; TAKAGI, Michiaki et al.The Journal of hand surgery (St. Louis, Mo.). 2007, Vol 32A, Num 9, pp 1413-1417, issn 0363-5023, 5 p.Article

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning : the role of dose intensitySHIMONI, A; HARDAN, I; SHEM-TOV, N et al.Leukemia. 2006, Vol 20, Num 2, pp 322-328, issn 0887-6924, 7 p.Article

Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantationCHUNDURI, S; DOBOGAI, L. C; RONDELLI, D et al.Bone marrow transplantation (Basingstoke). 2006, Vol 38, Num 7, pp 477-482, issn 0268-3369, 6 p.Article

High-dose busulfan and the risk of pulmonary mortality after autologous stem cell transplantKALAYCIO, Matt; POHLMAN, Brad; KUCZKOWSKI, Elizabeth et al.Clinical transplantation. 2006, Vol 20, Num 6, pp 783-787, issn 0902-0063, 5 p.Article

Population pharmacokiinetics of intravenous busulfan in patients undergoing hematopoietic stem cell transplantationTAKAMA, H; TANAKA, H; NAKASHIMA, D et al.Bone marrow transplantation (Basingstoke). 2006, Vol 37, Num 4, pp 345-351, issn 0268-3369, 7 p.Article

Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicityZWAVELING, J; BREDIUS, R. G. M; CREMERS, Sclm et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 1, pp 17-23, issn 0268-3369, 7 p.Article

Improved assay for determination of busulfan by liquid chromatography using postcolumn photolysisJENKE, Andreas; RENNER, Ulf; SCHULER, Ulrich S et al.Journal of chromatography. B. 2004, Vol 805, Num 1, pp 147-153, issn 1570-0232, 7 p.Article

Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamideLUND, M. B; BRINCH, L; KONGERUD, J et al.The European respiratory journal. 2004, Vol 23, Num 6, pp 901-905, issn 0903-1936, 5 p.Article

Intérêt clinique de l'adaptation des posologies du busulfan et de la ciclosporine chez des enfants greffés de moelle osseuse = Busulfan and cycosporin in bone graft childrenBERTOLLE, V; MARTIN, P; BLEYZAC, N et al.Annales pharmaceutiques françaises. 2004, Vol 62, Num 3, pp 165-176, issn 0003-4509, 12 p.Article

High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical productsBOULIGAND, Jérome; PACI, Angelo; MERCIER, Lionel et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 34, Num 3, pp 525-530, issn 0731-7085, 6 p.Article

New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 yearsSODANI, Pietro; GAZIEV, David; LUCARELLI, Barbarella et al.Blood. 2004, Vol 104, Num 4, pp 1201-1203, issn 0006-4971, 3 p.Article

Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myelomaCOGLE, Christopher R; MOREB, Jan S; LEATHER, Helen L et al.American journal of hematology. 2003, Vol 73, Num 3, pp 169-175, issn 0361-8609, 7 p.Article

Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignanciesTAUCHMANOVA, Libuse; SELLERI, Carmine; COLAO, Annamaria et al.Human reproduction (Oxford. Print). 2003, Vol 18, Num 7, pp 1410-1416, issn 0268-1161, 7 p.Article